Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 3
2005 5
2006 6
2007 3
2008 4
2009 3
2010 3
2011 4
2012 4
2013 3
2014 1
2015 3
2016 3
2017 2
2018 6
2020 2
2021 7
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Management of tumor volume changes during preoperative radiotherapy for extremity soft tissue sarcoma: a new strategy of adaptive radiotherapy.
De Lamarliere MG, Lusque A, Khalifa JA, Esteyrie V, Chevreau C, Valentin T, Gangloff D, Meresse T, Courtot L, Rochaix P, Boulet B, Graulieres E, Ducassou A. De Lamarliere MG, et al. Among authors: rochaix p. Radiol Oncol. 2023 Nov 30;57(4):507-515. doi: 10.2478/raon-2023-0056. eCollection 2023 Dec 1. Radiol Oncol. 2023. PMID: 38038424 Free PMC article.
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 Fusions.
Adam J, Stang NL, Uguen A, Badoual C, Chenard MP, Lantuéjoul S, Maran-Gonzalez A, Robin YM, Rochaix P, Sabourin JC, Soubeyran I, Sturm N, Svrcek M, Vincent-Salomon A, Radosevic-Robin N, Penault-Llorca F. Adam J, et al. Among authors: rochaix p. Mod Pathol. 2023 Aug;36(8):100192. doi: 10.1016/j.modpat.2023.100192. Epub 2023 Apr 20. Mod Pathol. 2023. PMID: 37084942
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.
Paillasse MR, Esquerré M, Bertrand FA, Poussereau-Pomié C, Pichery M, Visentin V, Gueguen-Dorbes G, Gaujarengues F, Barron P, Badet G, Briaux A, Ancey PB, Sibrac D, Erdociain E, Özcelik D, Meneyrol J, Martin V, Gomez-Brouchet A, Selves J, Rochaix P, Battistella M, Lebbé C, Delord JP, Dol-Gleizes F, Bono F, Blanc I, Alam A, Hunneyball I, Whittaker M, Fons P. Paillasse MR, et al. Among authors: rochaix p. Cancer Res Commun. 2022 Nov 29;2(11):1504-1519. doi: 10.1158/2767-9764.CRC-22-0151. eCollection 2022 Nov. Cancer Res Commun. 2022. PMID: 36970050 Free PMC article.
Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas.
Darbo E, Pérot G, Darmusey L, Le Guellec S, Leroy L, Gaston L, Desplat N, Thébault N, Merle C, Rochaix P, Valentin T, Ferron G, Chevreau C, Bui B, Stoeckle E, Ranchere-Vince D, Méeus P, Terrier P, Piperno-Neumann S, Collin F, De Pinieux G, Duffaud F, Coindre JM, Blay JY, Chibon F. Darbo E, et al. Among authors: rochaix p. Cancers (Basel). 2023 Jan 15;15(2):534. doi: 10.3390/cancers15020534. Cancers (Basel). 2023. PMID: 36672483 Free PMC article.
EBUS-TBNA for the diagnosis of primary pulmonary artery sarcoma.
Villeneuve T, Chevreau C, Pontier S, Prévot G, Rochaix P, Courtade-Saidi M, Guibert N. Villeneuve T, et al. Among authors: rochaix p. Respir Med Res. 2023 Jun;83:100974. doi: 10.1016/j.resmer.2022.100974. Epub 2022 Nov 17. Respir Med Res. 2023. PMID: 36436419 No abstract available.
Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome.
Benhaddou A, Gaston L, Pérot G, Desplat N, Leroy L, Le Guellec S, Ben Haddou M, Rochaix P, Valentin T, Ferron G, Chevreau C, Bui B, Stoeckle E, Le Cesne A, Piperno-Neumann S, Collin F, Firmin N, De Pinieux G, Coindre JM, Blay JY, Chibon F. Benhaddou A, et al. Among authors: rochaix p. Sci Rep. 2021 Dec 6;11(1):23429. doi: 10.1038/s41598-021-02787-x. Sci Rep. 2021. PMID: 34873180 Free PMC article.
Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer.
Gomez-Roca C, Even C, Le Tourneau C, Basté N, Delord JP, Sarini J, Vergez S, Temam S, Hoffmann C, Rochaix P, Borcoman E, Gavillet B, Rouits E, Ménétrey A, Brichory F, Purcea D, Vuagniaux G, Zanna C. Gomez-Roca C, et al. Among authors: rochaix p. Clin Transl Sci. 2022 Jan;15(1):55-62. doi: 10.1111/cts.13002. Epub 2021 Nov 11. Clin Transl Sci. 2022. PMID: 33742767 Free PMC article.
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.
Montfort A, Bertrand F, Rochotte J, Gilhodes J, Filleron T, Milhès J, Dufau C, Imbert C, Riond J, Tosolini M, Clarke CJ, Dufour F, Constantinescu AA, Junior NF, Garcia V, Record M, Cordelier P, Brousset P, Rochaix P, Silvente-Poirot S, Therville N, Andrieu-Abadie N, Levade T, Hannun YA, Benoist H, Meyer N, Micheau O, Colacios C, Ségui B. Montfort A, et al. Among authors: rochaix p. Cancer Immunol Res. 2021 May;9(5):568-582. doi: 10.1158/2326-6066.CIR-20-0342. Epub 2021 Mar 16. Cancer Immunol Res. 2021. PMID: 33727246 Free PMC article.
69 results